Combigan 0.2 % / 0.5 % Ophthalmic Solution
- RxCUI
- 861637
- RxNorm name
- Combigan 0.2 % / 0.5 % Ophthalmic Solution
- Display name
- Combigan 0.2 % / 0.5 % Ophthalmic Solution
- Full name
- Combigan 0.2 % / 0.5 % Ophthalmic Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| COMBIGAN | BRIMONIDINE TARTRATE, TIMOLOL MALEATE | Allergan, Inc. | feaf1480-a4b8-4486-992a-96be3a596243 | 2026-03-17 | Warnings, Adverse reactions | 861637 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| feaf1480-a4b8-4486-992a-96be3a596243 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Combigan] | SBD | 22 | These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 2007 | 20260317 |
| feaf1480-a4b8-4486-992a-96be3a596243 | Combigan (brimonidine tartrate 0.2 % / timolol 0.5 % ) Ophthalmic Solution | SY | 22 | These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 2007 | 20260317 |
| feaf1480-a4b8-4486-992a-96be3a596243 | Combigan 0.2 % / 0.5 % Ophthalmic Solution | PSN | 22 | These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 2007 | 20260317 |
| 8c641b6c-3335-4ec3-89b9-2d97a8901062 | Combigan (brimonidine tartrate 0.2 % / timolol 0.5 % ) Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 2007 | 20110415 |
| 8c641b6c-3335-4ec3-89b9-2d97a8901062 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Combigan] | SBD | 1 | These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 2007 | 20110415 |
| 8c641b6c-3335-4ec3-89b9-2d97a8901062 | Combigan 0.2 % / 0.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 2007 | 20110415 |